Wednesday, July 7, 2021

AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome

 

 

Lauren Briggs is one of the survivors of the widely reported but rare blood clotting associated with the AstraZeneca COVID-19 vaccine in the U.K. The blood clots that Lauren survived are considered “very rare” by The European Medicines Agency. The EMA has maintained that the benefits of using AstraZeneca‘s vaccine continue outweigh any risks, as has Health Canada. Yet for Lauren, it all started 10 days after getting the vaccine, when she woke up breathless, with high fever and a “horrendous headache,” which then led her to believe she might have contracted the coronavirus. However, upon getting tested, her reports came up negative, although her symptoms persisted. Lauren speaks with Global’s Dawna Friesen about her situation. For more info, please go to https://globalnews.ca/news/7760045/as...

 Health Canada  AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome 

Related 

 https://shore-215.blogspot.com/2021/07/naci-says-to-wait-on-2nd-mrna-covid-19.html

 https://shore-215.blogspot.com/2021/07/care-worker-needs-care-workers-after.html

 Check this out . Check this out page 16.

No comments:

Post a Comment